Symbol="ENTA"
AssetType="Common Stock"
Name="Enanta Pharmaceuticals Inc"
Description="Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. The company is headquartered in Watertown, Massachusetts."
CIK="1177648"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="500 ARSENAL STREET, WATERTOWN, MA, US"
FiscalYearEnd="September"
LatestQuarter="2023-06-30"
MarketCapitalization="328675000"
EBITDA="-130868000"
PERatio="None"
PEGRatio="0"
BookValue="11.29"
DividendPerShare="0"
DividendYield="0"
EPS="-5.92"
RevenuePerShareTTM="3.857"
ProfitMargin="-1.639"
OperatingMarginTTM="-1.653"
ReturnOnAssetsTTM="-0.189"
ReturnOnEquityTTM="-0.459"
RevenueTTM="80589000"
GrossProfitTTM="86160000"
DilutedEPSTTM="-5.92"
QuarterlyEarningsGrowthYOY="-0.662"
QuarterlyRevenueGrowthYOY="-0.03"
AnalystTargetPrice="30.22"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="10.58"
PriceToBookRatio="2.88"
EVToRevenue="8.14"
EVToEBITDA="-5.8"
Beta="0.369"
num_52WeekHigh="69.61"
num_52WeekLow="15.02"
num_50DayMovingAverage="19.96"
num_200DayMovingAverage="36.39"
SharesOutstanding="21055400"
DividendDate="None"
ExDividendDate="None"
symbol="ENTA"
open="15.44"
high="16.00"
low="15.44"
price="15.61"
volume="238051.00"
latest_trading_day="2023-08-18"
previous_close="15.66"
change="-0.05"
change_percent="-0.3193%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="100"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="0"
Volume_recent_avg="212666"
Change_recent_avg="-0.13"
Delta_recent_avg="1.2"
Variance_recent_avg="0.6"
Change_ratio_recent_avg="-0.5"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="0"
Aroon_momentum_negative="100"
image_negative_thumbnail_id_1="510"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0095.jpeg"
image_negative_thumbnail_id_2="1106"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0139.jpeg"
image_neutral_thumbnail_id_1="549"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0050.jpeg"
image_neutral_thumbnail_id_2="588"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0011.jpeg"
image_positive_thumbnail_id_1="673"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0035.jpeg"
image_positive_thumbnail_id_2="690"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0018.jpeg"
image_professor_thumbnail_id_1="1175"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0009.jpeg"
image_professor_thumbnail_id_2="1177"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0011.jpeg"
